David Lu
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 19
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 7
-
- Prostate Cancer Treatment and Research 10
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Ryan Dittamore (19 shared papers)Ryon P. Graf (15 shared papers)Howard I. Scher (9 shared papers)Nicole A. Schreiber (9 shared papers)Glenn Heller (5 shared papers)Martin Fleisher (6 shared papers)Brigit McLaughlin (6 shared papers)Jessica Louw (14 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (5 papers)JAMA Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David Lu
27 papers receiving 1.2k citations
David Lu's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 594
- Pulmonary and Respiratory Medicine 800
- Oncology 549
- Endocrinology, Diabetes and Metabolism 118
- Molecular Biology 361
Countries citing papers authored by David Lu
This map shows the geographic impact of David Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lu more than expected).
Fields of papers citing papers by David Lu
This network shows the impact of papers produced by David Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lu. The network helps show where David Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2016 | 461 |
| 2 | 2018 | 160 | |
| 3 | 2016 | 129 | |
| 4 | 2017 | 94 | |
| 5 | 2016 | 90 | |
| 6 | 2014 | 75 | |
| 7 | 2017 | 61 | |
| 8 | 2019 | 38 | |
| 9 | 2004 | 25 | |
| 10 | 1986 | 21 | |
| 11 | 2022 | 17 | |
| 12 | 2011 | 15 | |
| 13 | 2016 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2018 | 7 | |
| 17 | 2019 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2015 | 4 | |
| 20 | 2016 | 3 |
About David Lu
David Lu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Cells and Metastasis (9 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Lung Cancer Treatments and Mutations (5 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (594 citations), Pulmonary and Respiratory Medicine (800 citations), Oncology (549 citations), Endocrinology, Diabetes and Metabolism (118 citations) and Molecular Biology (361 citations). David Lu has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ryan Dittamore, Ryon P. Graf, Howard I. Scher, Nicole A. Schreiber, Glenn Heller, Martin Fleisher, Brigit McLaughlin, Jessica Louw, Adam Jendrisak and Ann Johnson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JAMA Oncology, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.